Advances in Neuron Sciences Welcomes New Editorial Board Member

We sincerely welcome Prof. Dr. Alberto Lazarowski from Institute of Pathophysiology and Clinical Biochemistry (INFIBIOC), Faculty of Pharmacy and Biochemistry (FFyB)-University of Buenos Aires (UBA) to join the Editorial Board of Advances in Neuron Sciences. Alberto Lazarowski, PhD, is a biochemist trained at the School of Pharmacy and Biochemistry (FFyB) at the University of Buenos Aires, Argentina. He earned a masters in molecular biology and genetic engineering and a doctorate studying the role of folic acid in epileptic seizures in children. Currently, he is a professor of clinical biochemistry in the Department of Pharmacy and Biochemistry at the University of Buenos Aires. He was a postdoctoral fellow of the UICC (International Union Against Cancer), studying the MDR gene at UNC–Chapel Hill, and later he described for the first time the role of the MDR-1 gene in Argentine children with refractory epilepsy. Later, he developed the confirmatory experimental studies in rats at the IBCN (Instituto de Biología Celular y Neurociencias, “Prof. E. de Robertis,” School of Medicine, University of Buenos Aires).Together with his wife, Dr. Liliana Czornyj (MD, Child Neurologist) , they have studied several cases of pharmacoresistant epilepsies in children with overexpression of different ABC transporters in the brain epileptogenic areas associated with pharmacokinetic modifications of some AEDs and described the potential role of multidrug resistant proteins in refractory epilepsy and antiepileptic drug interactions. Both are members of GENIAR, an Ibero-Latin-American network of researchers in neuroscience (CYTED #610RT0405). He has conducted studies of nasal administration of EPO to prevent damage from experimental focal cortical cerebral ischemia. He currently directs projects related to the use of CBD and EPO in experimental models of refractory epilepsies and the mechanisms of ferroptosis in neurodegeneration, heart failure and SUDEP. There are currently research projects on neurodegeneration mediated by ferroptosis in refractory epilepsies, the development of nanoparticles for the nasal transport of protective products from neurodegeneration as well as anticonvulsant drugs, on the potential antiepileptogenic effect of CBD and its role as an ABC inhibitor. transporters and CYP We appreciate Prof. Dr. Alberto Lazarowski for his participation and support.